[ap-intact] NEW PUBLICATION: Asia-Pacific Fraud Survey 2015 - A life sciences perspective

[Facilitator's note: Thank you to Anga R. Timilsina, Programme Manager, UNDP’s Global Anti-corruption Initiative (GAIN), for sharing this information.]

According to Ernst & Young's (EY) Asia-Pacific Fraud Survey 2015: a life sciences perspective, almost three-quarters of life sciences respondents agree that corruption happens widely in their sector – significantly higher than the Asia-Pacific average.

More in EY. http://www.ey.com/SG/en/Services/Assurance/Fraud-Investigation---Dispute-Services/EY-growing-fraud-and-corruption-risks-life-sciences?utm_source=EYCOM&utm_medium=FIDSRHF&utm_campaign=APAC-Fraud-Survey-life-sciences

Note: The survey defines the life sciences sector as comprising pharmaceutical companies, biotechnology companies, medical technology companies and supporting entities such as outsource manufacturers and distributors.

Popular posts from this blog

The Pacific - Nepal - Eastern Europe & Central Asia

Middle East & North Africa - Ukraine - Sri Lanka

Global - Sub-Saharan Africa - Turkey & Syria